Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
APGE
#1022
Apogee Therapeutics, Inc. - Common Stock
134.9
6
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+0.60%
6 month change
+100.36%
Year Change
+151.84%
Previous Close
134.9
6
Open
134.9
7
Low
134.9
6
High
134.9
7
Volume
41
Markets
US Stock Market
Healthcare
Biotechnology
APGE
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2023
2024
2025
Current
Key stats
Total common shares outstanding
37.17 M
46.02 M
56 M
75.69 M
Valuation ratios
Enterprise value
941.37 M
1.94 B
4.1 B
8.28 B
Price to earnings ratio
-8.49
-13.73
-17.89
-31.08
Price to sales ratio
—
—
—
—
Price to cash flow ratio
-9.54
-14.61
-20.14
-36.46
Price to book ratio
1.14
1.88
5.07
1.7
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
-0.21
-0.24
-0.27
-0.06
Return on equity %
-0.22
-0.25
-0.28
0.03
Return on invested capital %
-9 082.32
-749.3
-573.88
134.75
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
19.38
18.55
26.57
26.44
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
-2.99
-3.1
-3.75
-3.7
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
15.81
9.43
12.03
13.39
Net current asset value per share
15.93
9.6
12.22
13.15
Tangible book value per share
15.19
12.99
14.89
36.42
Working capital per share
15.11
9.08
11.76
12.65
Book value per share
15.19
12.99
14.89
36.42
News
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
3 Best ETFs With 50%+ Upside to Buy in August 2026, According to Analysts - TipRanks.com
Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review
Botox Maker Tops Buy Point, But Here Comes The Earnings Report
Is Apogee Therapeutics Inc. (APGE) Stock Outpacing Its Medical Peers This Year?
AbbVie Stock: A Dividend Fortress At An Appealing Price Tag (NYSE:ABBV)
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
Biotech Euphoria Driven By Fundamentals
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?
U.S. Equity Markets: Lots Of Gambling Going On